Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

HNX:DP3 Revenue

Central Pharmaceutical Joint Stock Company No3 had revenue of 120.23B VND in the quarter ending September 30, 2025, with 26.26% growth. This brings the company's revenue in the last twelve months to 422.55B, up 5.82% year-over-year. In the year 2024, Central Pharmaceutical Joint Stock Company No3 had annual revenue of 417.49B with 1.89% growth.

• Revenue (ttm): 422.55B
• Revenue Growth: +5.82%
• P/S Ratio: 2.65
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.12T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	417.49B	7.75B	1.89%
Jan 1, 2024	409.73B	-75.34B	-15.53%
Dec 31, 2022	485.07B	104.00B	27.29%
Dec 31, 2021	381.08B	-14.64B	-3.70%
Dec 31, 2020	395.72B	-15.71B	-3.82%